About 2 results found for searched term "CFI-402257" (0.124 seconds)
Cat.No. | Name | Target |
---|---|---|
M6078 | CFI-402257 | Others |
CFI-402257 is a highly selective and orally bioavailable TTK and Mps1 inhibitor with Kis of 0.1 and 0.09 nM, respectively. | ||
M56001 | Luvixasertib hydrochloride | Mps1/TTK |
CFI-402257 hydrochloride is a highly selective and orally bioavailable TTK/Mps1 inhibitor with an IC50 of 1.7 nM for TTK in vitro. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.